AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2021
Oct 13, 2021
30016_dirs_2021-10-13_29326e3c-c916-4751-a12a-61c278245322.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-10-11
Reporting Person: Claflin Bruce L. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-11 | Common Stock | M | 1921 | $160.28 | Acquired | 1921 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-11 | Non-Qualified Stock Option (right-to-buy) | $160.28 | M | 1921 | Disposed | 2027-05-02 | Common Stock (1921) | Direct |
Footnotes
F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2018.
F2: Not applicable.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13